Kyntra Bio, Inc. · NASDAQ:KYNB

Wettig Thane received 2,500 Kyntra Bio, Inc. shares as an award (Form 4)

Traded Nov 15, 2026 · Filed Nov 17, 2026

On Nov 15, 2026, Wettig Thane (Director, CEO) received 2,500 Kyntra Bio, Inc. shares as an award at US$2.92 for US$7,310, leaving 29,296 shares. Filed Nov 17, 2026 (Form 4).

Awarded
2,500 shares
Price
US$2.92
Value
US$7,310
Holding after
29,296 shares
Trading plan
No
Role
Director, CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 15, 2026Common StockAward2,500US$2.9229,296Direct

Source

Download original · View original at SEC

Related